Eva Kempers &
Marieke J.H.A. Kruip/LinkedIn
Aug 17, 2025, 08:21
Eva Kempers: Menstrual Blood Loss and Quality of Life in Antiplatelet Therapy
Research and Practice in Thrombosis and Haemostasis (RPTH) shared a study by Eva Kempers, Postdoctoral researcher at the University of Antwerp, on LinkedIn :
“This study from Eva Kempers and team examined menstrual blood loss and related quality of life among women on antiplatelet therapy and a control group.
Their data reveal that both outcomes were comparable, great news for women who need antiplatelet therapy.”
Read the full article here.
Article: Menstrual bleeding-specific quality of life in women on antiplatelet therapy
Authors: Eva K. Kempers, Johanna A. van der Zande, Paula M. Janssen, Jérôme M.J. Cornette, Jolien W. Roos–Hesselink
Senior author: Marieke J.H.A. Kruip

Find the newest developments in clotting science in Hemostasis Today.
Antiplatelet Therapy
Eva Kempers
Health
Hematology
Hemostasis Today
Jérôme M.J. Cornette
Johanna A. van der Zande
Jolien W. Roos–Hesselink
Marieke J.H.A. Kruip
Medicine
menstrual bleeding
menstrual blood loss
Paula M. Janssen
Research and Practice in Thrombosis and Haemostasis
RPTH Journal
University of Antwerp
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
